FDA grants swift approval to Cognoa’s digital device for autism diagnosisThe FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum Share XFDA grants swift approval to Cognoa’s digital device for autism diagnosishttps://pharmaphorum.com/news/fda-grants-swift-approval-to-cognoas-digital-device-for-autism-diagnosis/
UK hospital deploys Microsoft AI to tackle cancer backlogAddenbrooke’s Hospital in Cambridge will be the first in the world to use an artificial intelligence tool developed Share XUK hospital deploys Microsoft AI to tackle cancer backloghttps://pharmaphorum.com/news/uk-hospital-deploys-microsoft-ai-to-tackle-cancer-backlog/
Cognoa preps FDA filing for digital autism diagnosticAn artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in Share XCognoa preps FDA filing for digital autism diagnostichttps://pharmaphorum.com/news/cognoa-preps-fda-filing-for-digital-autism-diagnostic/
Illumina wants to bring liquid biopsy spinout Grail back in-house; reportCancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite Share XIllumina wants to bring liquid biopsy spinout Grail back in-house; reporthttps://pharmaphorum.com/news/illumina-wants-to-bring-liquid-biopsy-spinout-grail-back-in-house-report/
UK medical journals spar over breast cancer screening studyScreening women for breast cancer in their 40s rather than their 50s could save lives, say the authors Share XUK medical journals spar over breast cancer screening studyhttps://pharmaphorum.com/news/uk-medical-journals-spar-over-breast-cancer-screening-study/
Government warned over test and trace as UK schools prep to reopenThe current level of test and trace in the UK is inadequate to prevent a sharp increase in Share XGovernment warned over test and trace as UK schools prep to reopenhttps://pharmaphorum.com/news/government-warned-over-test-and-trace-as-uk-schools-prep-to-reopen/
Japan trials app to help coronavirus patients recover at homeA smartphone app developed by medical software specialist Allm is being trialled in Japan to see if it Share XJapan trials app to help coronavirus patients recover at homehttps://pharmaphorum.com/news/japan-trials-app-to-help-coronavirus-patients-recover-at-home/
AI health record scanning could identify pancreatic cancer earlyArtificial intelligence (AI) could hold the key to identifying people at risk of pancreatic cancer early, allowing them Share XAI health record scanning could identify pancreatic cancer earlyhttps://pharmaphorum.com/news/ai-health-record-scanning-could-identify-pancreatic-cancer-early/
Roche signs up with Oncimmune to explore immunotherapy responsesRoche has doubled down on a partnership with UK biotech Oncimmune looking at how autoantibodies can affect patients’ Share XRoche signs up with Oncimmune to explore immunotherapy responseshttps://pharmaphorum.com/news/roche-signs-up-with-oncimmune-to-explore-immunotherapy-responses/
